Document ID: EPA-HQ-OPP-2005-0258-0002
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2006-02-15T05:00Z

Triadimefon
Reader
=

s
Guide
1
Reader
=

s
Guide
to
Triadimefon
Docket
#
EPA­
HQ­
OPP­
2005­
0258
EPA
has
created
this
document
to
provide
an
organizational
structure
to
the
Triadimefon
Docket.
The
docket
index
groups
related
documents.
The
first
group
contains
the
Federal
Register
and
Docket
Organizational
Documents;
the
second
group
contains
Human
Health
Risk
Assessment
Documents
for
Phase
3
Public
Comments,
and
the
third
group
contains
the
Environmental
Risk
Assessment
documents.
The
Agency
is
providing
the
A
Reader
=

s
Guide
@

to
allow
the
reader
to
more
easily
access
and
navigate
the
various
items
contained
in
the
Triadimefon
docket.

Federal
Register
and
Docket
Organizational
Documents:

Docket
Item
1.
Federal
Register
Notice:
Triadimefon
Risk
Assessment;
Notice
of
Availability,
and
Risk
Reduction
Options
(
Phase
3
of
4­
Phase
Process)

This
document
formally
and
publicly
announces
that
the
triadimefon
risk
assessments
are
available
for
review
on
the
internet
or
at
the
EPA
=

s
Office
of
Pesticides
Programs
=

Public
Docket
and
solicits
comments
and
suggestions
on
the
risk
assessment
and
how
to
mitigate
or
address
potential
risks
of
concern.

Docket
Item
2.
Reader
=

s
Guide
to
the
Triadimefon
Docket
#
EPA­
HQ­
OPP­
2005­
0258
This
document
is
designed
to
annotate
all
the
documents
in
the
Triadimefon
Docket.

Human
Health
Risk
Assessment
Documents
for
Phase
3
Public
Comments
Docket
Item
3.
Triadimefon.
Preliminary
Human
Health
Risk
Assessment
(
Revised)
Griffin
2/
9/
06
This
document
describes
all
the
human
health
risks
from
the
use
of
triadimefon
including
erroronly
revisions
based
on
registrant
comments.

Docket
Item
4.
Triadimefon.
Acute
and
Chronic
Dietary
Exposure
Assessments
for
the
Reregistration
Eligibility
Decision
(
RED)
Document
11/
23/
05
Ary
This
document
describes
the
potential
risk
to
the
US
general
population
and
population
subgroups
from
food
and
drinking
water
containing
triadimefon
residues
in/
on
them.
Triadimefon
Reader
=

s
Guide
2
Docket
Item
5.
Triadimefon.
Preliminary
Human
Health
Risk
Assessment
11/
23/
05
Griffin
This
is
the
preliminary
human
health
risk
assessment
document
(
prior
to
error
correction)
that
describes
all
the
human
health
risks
from
the
use
of
triadimefon.

Docket
Item
6.
Triadimefon:
Summary
of
Product
Chemistry
Data
for
Reregistration
Eligibility
Decision
(
RED)
Document
11/
22/
05
Barnes
This
document
describes
physical
and
chemical
characteristics
of
the
technical
product
that
contain
triadimefon.

Docket
Item
7.
Triadimefon.
Summary
of
Analytical
Chemistry
and
Residue
Data
for
the
Reregistration
Eligibility
Decision
(
RED)
Document
11/
23/
05
Ary
This
document
reports
on
the
fate
and
metabolic
pathways
of
the
active
ingredient,
triadimefon.
It
describes
how
much
triadimefon
is
likely
to
remain
in
food
after
use
over
time.

Docket
Item
8.
Review
of
Triadimefon
Incident
Reports
(
includes
127201,
triadimenol)
8/
24/
2005
Hawkins
This
document
reports
on
the
documented
poisoning
incident
data
involving
triadimefon
and
triadimenol.

Docket
Item
9.
Triadimefon:
Occupational
and
Residential
Exposure
Assessment
for
the
Reregistration
Eligibility
Decision
Document
11/
17/
05
Recore
This
document
describes
the
potential
risks
to
workers
and
homeowners
who
come
in
contact
with
triadimefon
residues.

Docket
Item
10.
Note
to
Reader
memo
(
Triazoles)
2/
8/
06
Special
Review
and
Reregistration
Division
This
document
describes
the
Agency's
current
process
for
reviewing
the
registration
of
three
fungicide
pesticides
(
triadimefon,
triadimenol,
and
propiconazole)
who
share
the
common
metabolites
1,2,4­
triazole,
triazole
alanine,
and
triazole
acetic
acid.
Triadimefon
Reader
=

s
Guide
3
Docket
Item
11.
Occupational
and
Residential
Exposure/
Risk
Assessment
of
1,2,4­
Triazole
12/
9/
05
Arthur
This
document
describes
the
potential
risks
to
workers
and
homeowners
who
come
in
contact
with
1,2,4­
Triazole
residues.

Docket
Item
12.
1,2,4­
Triazole.
Acute
and
Chronic
Dietary
Exposure
Assessments
to
Support
Reregistration
and
Registration
Actions
for
Triazole­
derivative
Fungicides
11/
1/
05
Doherty
This
document
describes
the
acute
and
chronic
dietary
risks
(
1,2,4­
triazole
as
a
terminal
residue)
associated
with
food
consumption
through
the
conjugated
metabolites
triazole
alanine
and
triazole
acetic
acid.

Docket
Item
13.
Triazole
Alanine
and
Triazole
Acetic
Acid.
Acute
and
Chronic
Dietary
Exposure
Assessments
to
Support
Reregistration
and
Registration
Actions
for
Triazole­
derivative
Fungicides
12/
20/
05
Doherty
This
document
describes
the
acute
and
chronic
dietary
risks
(
1,2,4­
triazole
as
a
terminal
residue)
associated
with
food
consumption
through
the
conjugated
metabolites
triazole
alanine
and
triazole
acetic
acid.

Docket
Item
14.
1,2,4­
Triazole,
Triazole
Alanine,
Triazole
Acetic
Acid:
Human
Health
Aggregate
Risk
Assessment
in
Support
of
Reregistration
and
Registration
Actions
for
Triazole­
derivative
Fungicide
Compounds
2/
7/
06
Doherty
This
document
describes
the
evaluation
of
risks
for
various
population
subgroups,
including
those
comprised
of
infants
and
children.

Environmental
Fate
and
Effects
Documents
for
Phase
3
Public
Comment
Docket
Item
15.
Environmental
Fate
and
Effects
Chapter
(
Revised)
1/
19/
06
Embry
This
document
describes
the
toxicity
of
triadimefon
to
animals
and
plants
in
the
environment.
It
also
describes
the
breakdown
and
fate
of
triadimefon
and
its
metabolites
in
the
environment
including
error­
only
revisions
based
on
registrant
comments.
Triadimefon
Reader
=

s
Guide
4
Docket
Item
16.
Memorandum.
Environmental
Fate
and
Effects
Division
Error­
only
Corrections
and
revised
Triadimefon
RED
1/
19/
06
Embry
This
document
is
the
cover
memo
to
the
revised
Environmental
Fate
and
Effects
Chapter
that
describes
the
Agency's
response
to
error­
only
comments
submitted
by
the
registrant.

Docket
Item
17.
Ecological
Risk
Assessment
in
Support
of
the
Reregistration
Eligibility
Decision
on
Triadimefon
8/
30/
05
Embry
This
document
describes
the
toxicity
of
triadimefon
to
animals
and
plants
in
the
environment.
It
also
describes
the
breakdown
and
fate
of
triadimefon
and
its
metabolites
in
the
environment.

Docket
Item
18.
Memorandum.
Environmental
Fate
and
Effects
Chapter.
Environmental
Fate
and
Ecological
Risk
Assessment
for
Triadimefon
8/
30/
05
Embry
This
document
is
the
cover
memo
to
the
Agency's
ecological
risk
assessment
for
triadimefon.

Docket
Item
19.
Tier
2
Drinking
Water
Assessment
for
Triadimefon
and
its
Major
Degradate
Triadimenol
8/
31/
05
Angier
This
document
describes
how
much
triadimefon
and
other
metabolites
may
be
found
in
drinking
water
after
application.